A systems biology approach to oncology drug development [electronic resource] : clinical testing of biomarkers for the anti-ErbB3 antibody MM-121 / Birgit Schoeberl.
Material type:
FilmSeries: Henry Stewart talksBiomedical & life sciences collection. Systems biology: Publisher: London : Henry Stewart Talks, 2015Description: 1 online resource (1 streaming video file (33 min.) : color, sound)Subject(s): Antineoplastic agents -- Development | Computational biology | Drug development | Pharmaceutical technology -- Data processing | Antibodies, Monoclonal -- pharmacology | Antineoplastic Agents -- pharmacology | Cell Line, Tumor | Drug Design | Drug Discovery | Genes, erbB | Ligands | Neoplasms -- drug therapy | Receptor, ErbB-3 -- antagonists & inhibitors | Receptor, ErbB-3 -- immunology | Systems Biology | Technology, Pharmaceutical -- methodsOnline resources: Click here to access online | Series Animated audio-visual presentation with synchronized narration.
Title from title frames.
Contents: Oncology drug development -- Network biology -- The HRG family of ligands -- The ErbB pathway -- MM-121 mechanism of action -- Data from in-vitro and iv-vivo experiments using MM-121 -- Timeline of MM-121: 2003-2015.
Access restricted to subscribers.
Mode of access: World Wide Web.